Inventurus Knowledge Solutions Limited (NSE: IKS), a leading technology-enabled healthcare solutions provider and care enablement platform for the US Healthcare industry, today announced its robust financial results for the fiscal year and quarter ended March 31, 2026. The company, widely recognized as IKS Health, reported an exceptional performance, driven by a 20% year-on-year (YoY) revenue growth and a significant 48% surge in Profit After Tax (PAT) for the full financial year 2026.
Key Financial Highlights: FY 2026
Consolidated Financial Highlights for the Financial Year 2025-26
Key Financial Highlights: Q4 FY26
Consolidated Financial Highlights for the Quarter ended March 31, 2026:
“Our performance this fiscal year underscores the deep value we bring to clinician enterprises as they navigate an increasingly complex US healthcare landscape. Ending the year with a strong 20% YoY revenue growth in FY 2026 is a testament to the scalability of our care enablement platform,” said Sachin K. Gupta, Founder & CEO, IKS Health. “Our 'AI + Human' model is now the industry standard for sustainable growth, as proven by our expanding partnerships with top-tier health systems. By deploying autonomous engines and agentic AI like MyCareHub™, we are providing the clinical and financial intelligence needed to transform care delivery. We enter FY27 with the financial strength to accelerate this AI-driven momentum.”
Nithya Balasubramanian, CFO, IKS Health, said, “Our fiscal year concluded with exceptional operational discipline, reflected in our 38% YoY EBITDA growth and significant margin expansion. The 48% rise in PAT for the year demonstrates our ability to scale efficiently and deliver profitable growth through a resilient business model which leverages the latest technology and global delivery. With a strong balance sheet and robust cash flow generation, we are well-positioned to continue investing in our technology platform to drive long-term, sustainable value for our shareholders.”
Business Highlights:
Safe Harbour
Certain statements in this release concerning our future growth prospects may be seen as forward-looking statements, which involve a number of risks and uncertainties that could cause the actuals to differ materially from such statements. It is not possible to undertake to update any such statement that may have been made from time to time.
